Current status and future prospects of immunotherapy for pancreatic ductal adenocarcinoma
{{output}}
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive and prevalent malignancy challenged by early detection, frequent presentation at advanced stages, and high likelihood of postoperative recurrence and metastasis. Despite ongoing research efforts, t... ...